Nae'Qwan Tomlin: Everything you need to know

Nae'Qwan Tomlin

#35 PF

Cleveland Cavaliers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

5.9

3.0

0.8

0.5

0.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	64	3	15.7	5.8	2.9	0.8	0.5	0.6	0.5	0	0.4	1.8	23.5%	1.9	3.1	61.8%	2.3	4.9	47.8%	0.7	1.0	77.0%	1.3	1.6	2.0	1.8	+60	54.9%
2024-25	5	1	12.6	7.2	4.2	0.4	0.2	0.0	0.4	1	0.4	2.0	20.0%	2.2	4.4	50.0%	2.6	6.4	40.6%	1.6	2.2	72.7%	1.8	2.4	1.8	1.0	+7	48.9%
Career	69	4	15.5	5.9	3.0	0.8	0.5	0.6	0.4	1	0.4	1.8	23.2%	1.9	3.2	60.6%	2.4	5.0	47.1%	0.8	1.0	76.4%	1.4	1.6	1.9	1.8	+67	54.3%

Career Averages

PTS

REB

AST

BLK

STL

1.0

0.5

0.0

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	2	0	2.5	1.0	0.5	0.5	0.0	0.0	0.5	0	0	0.0	0.0	0.0%	0.5	1.0	50.0%	0.5	1.0	50.0%	0.0	0.0	0.0%	0.5	0.0	1.0	1.0	-2	50.0%
Career	2	0	2.5	1.0	0.5	0.5	0.0	0.0	0.5	0	0	0.0	0.0	0.0%	0.5	1.0	50.0%	0.5	1.0	50.0%	0.0	0.0	0.0%	0.5	0.0	1.0	1.0	-2	50.0%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/14	DET	W 118-100	2	3	1	0	0	1	0	1	1	100.0%	0	0	0.0%	1	1	100.0%	0	0	0.0%	0	1	0.0	+3	0	5	150.0%
10/12	BOS	L 138-107	24	8	4	2	0	1	1	6	2	33.3%	3	1	33.3%	9	3	33.3%	0	0	0.0%	1	3	2.0	-16	2	5	44.4%
10/9	CHI	L 119-112	17	1	1	0	0	0	0	3	0	0.0%	3	0	0.0%	6	0	0.0%	2	1	50.0%	0	1	0.0	-6	3	8	7.3%
10/7	CHI	L 118-117	18	11	3	0	0	2	0	3	1	33.3%	5	3	60.0%	8	4	50.0%	2	2	100.0%	2	1	0.0	+4	5	7	61.9%
Preseason Totals			15.8	5.8	2.3	0.5	0.0	1.0	0.3	3.3	1.0	30.8%	2.8	1.0	36.4%	6.0	2.0	33.3%	1.0	0.8	75.0%	0.8	1.5	2.0	-15	2.5	5.5	44.6%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	ATL	L 124-102	18	4	5	1	1	1	1	0	0	0.0%	4	2	50.0%	4	2	50.0%	0	0	0.0%	1	4	1.0	+10	3	4	50.0%
4/6	MEM	W 142-126	21	10	9	2	1	1	2	2	1	50.0%	5	3	60.0%	7	4	57.1%	1	1	100.0%	4	5	1.0	+12	2	18	67.2%
4/5	IND	W 117-108	13	3	4	0	1	0	1	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	1	3	0.0	+1	3	3	75.0%
3/31	LAL	L 127-113	22	9	3	1	0	0	1	5	1	20.0%	4	3	75.0%	9	4	44.4%	0	0	0.0%	2	1	1.0	-2	4	3	50.0%
3/30	UTA	W 122-113	9	4	3	0	1	0	0	0	0	0.0%	3	2	66.7%	3	2	66.7%	0	0	0.0%	1	2	0.0	+2	0	6	66.7%
3/27	MIA	W 149-128	5	0	0	1	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	-3	1	0	0.0%
3/25	MIA	L 120-103	17	6	4	0	0	0	0	0	0	0.0%	3	2	66.7%	3	2	66.7%	2	2	100.0%	2	2	0.0	-2	4	6	77.3%
3/24	ORL	W 136-131	6	0	1	0	1	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	1	0.0	+3	0	2	0.0%
3/21	NOP	W 111-106	3	0	0	0	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+1	1	3	0.0%
3/19	CHI	W 115-110	11	0	0	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	+3	0	0	0.0%
3/15	DAL	L 130-120	12	4	0	0	0	1	1	2	0	0.0%	2	2	100.0%	4	2	50.0%	0	0	0.0%	0	0	0.0	-9	2	0	50.0%
3/13	DAL	W 138-105	17	8	2	1	0	1	2	3	0	0.0%	4	4	100.0%	7	4	57.1%	1	0	0.0%	1	1	0.5	+15	3	5	53.8%
3/9	PHI	W 115-101	3	2	0	0	0	1	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	0	0	0.0	-8	0	2	100.0%
3/1	BKN	W 106-102	4	0	1	0	0	1	0	0	0	0.0%	3	0	0.0%	3	0	0.0%	0	0	0.0%	1	0	0.0	-4	1	3	0.0%
2/27	DET	L 122-119	14	2	2	0	1	1	0	1	0	0.0%	4	1	25.0%	5	1	20.0%	0	0	0.0%	1	1	0.0	+1	2	1	20.0%
2/25	MIL	L 118-116	8	2	2	0	0	0	2	2	0	0.0%	2	1	50.0%	4	1	25.0%	0	0	0.0%	1	1	0.0	-3	0	1	25.0%
2/24	NYK	W 109-94	2	0	0	0	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	-4	0	1	0.0%
2/22	OKC	L 121-113	9	0	2	0	0	0	0	1	0	0.0%	2	0	0.0%	3	0	0.0%	0	0	0.0%	2	0	0.0	+3	3	6	0.0%
2/20	CHA	W 118-113	12	5	2	1	0	0	0	2	1	50.0%	1	0	0.0%	3	1	33.3%	2	2	100.0%	1	1	0.0	+4	3	5	64.4%
2/11	WAS	W 138-113	15	8	5	0	0	2	1	2	0	0.0%	6	4	66.7%	8	4	50.0%	0	0	0.0%	4	1	0.0	-4	2	7	50.0%
2/9	DEN	W 119-117	12	6	1	0	1	0	0	2	2	100.0%	1	0	0.0%	3	2	66.7%	0	0	0.0%	0	1	0.0	-10	3	4	100.0%
2/7	SAC	W 132-126	16	6	5	2	0	0	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	2	3	0.0	+16	2	10	75.0%
2/4	LAC	W 124-91	20	4	1	2	2	2	0	4	0	0.0%	3	1	33.3%	7	1	14.3%	2	2	100.0%	0	1	0.0	+16	4	1	25.4%
2/1	POR	W 130-111	21	12	1	0	0	1	0	2	0	0.0%	6	5	83.3%	8	5	62.5%	2	2	100.0%	0	1	0.0	-7	1	9	67.6%
1/30	PHX	L 126-113	24	14	5	1	0	2	1	2	0	0.0%	7	6	85.7%	9	6	66.7%	2	2	100.0%	3	2	1.0	+14	3	16	70.9%
1/28	LAL	W 129-99	28	8	4	3	1	2	1	2	0	0.0%	4	4	100.0%	6	4	66.7%	0	0	0.0%	3	1	3.0	+8	2	13	66.7%
1/26	ORL	W 114-98	23	8	3	1	0	0	2	4	1	25.0%	3	1	33.3%	7	2	28.6%	4	3	75.0%	0	3	0.5	-5	1	4	45.7%
1/24	ORL	W 119-105	24	9	1	4	0	0	1	4	2	50.0%	1	1	100.0%	5	3	60.0%	2	1	50.0%	0	1	4.0	-8	5	8	76.5%
1/23	SAC	W 123-118	15	4	1	0	1	1	0	1	0	0.0%	3	2	66.7%	4	2	50.0%	0	0	0.0%	0	1	0.0	-27	4	1	50.0%
1/21	CHA	W 94-87	20	6	9	2	0	0	0	3	0	0.0%	4	3	75.0%	7	3	42.9%	0	0	0.0%	7	2	0.0	+0	1	12	42.9%
1/19	OKC	L 136-104	26	6	8	1	0	2	0	3	0	0.0%	4	3	75.0%	7	3	42.9%	0	0	0.0%	3	5	0.0	-10	2	11	42.9%
1/16	PHI	W 117-115	17	9	5	0	0	0	0	2	0	0.0%	7	4	57.1%	9	4	44.4%	1	1	100.0%	1	4	0.0	-7	4	5	47.7%
1/14	PHI	W 133-107	21	0	2	3	1	1	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	1	1	0.0	+3	3	3	0.0%
1/12	UTA	L 123-112	19	13	3	3	2	1	0	3	1	33.3%	8	5	62.5%	11	6	54.5%	0	0	0.0%	1	2	0.0	-3	1	15	59.1%
1/10	MIN	W 146-134	16	4	1	2	0	2	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	0	1	2.0	+0	3	5	100.0%
1/8	MIN	L 131-122	7	2	1	1	0	0	0	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	1	0	0.0	+5	1	3	100.0%
1/6	IND	W 120-116	20	7	3	1	1	0	1	3	1	33.3%	2	2	100.0%	5	3	60.0%	0	0	0.0%	1	2	1.0	+10	2	7	70.0%
1/4	DET	L 114-110	17	5	4	0	2	0	0	1	0	0.0%	3	1	33.3%	4	1	25.0%	4	3	75.0%	1	3	0.0	-4	2	5	43.4%
1/2	DEN	W 113-108	18	6	6	0	1	1	1	1	0	0.0%	4	2	50.0%	5	2	40.0%	2	2	100.0%	2	4	0.0	+6	1	10	51.0%
12/31	PHX	W 129-113	12	0	4	1	2	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	4	0.0	-7	1	5	0.0%
12/29	SAS	W 113-101	5	6	0	0	0	0	0	4	2	50.0%	1	0	0.0%	5	2	40.0%	0	0	0.0%	0	0	0.0	+1	0	3	60.0%
12/23	NOP	W 141-118	3	2	0	0	1	1	0	1	0	0.0%	1	1	100.0%	2	1	50.0%	0	0	0.0%	0	0	0.0	-3	0	3	50.0%
12/22	CHA	W 139-132	12	5	0	0	0	0	0	2	1	50.0%	2	1	50.0%	4	2	50.0%	0	0	0.0%	0	0	0.0	-1	0	3	62.5%
12/19	CHI	L 136-125	20	15	3	2	0	1	1	5	2	40.0%	9	4	44.4%	14	6	42.9%	2	1	50.0%	1	2	2.0	-2	1	10	50.4%
12/17	CHI	L 127-111	7	2	1	1	0	0	0	1	0	0.0%	1	0	0.0%	2	0	0.0%	4	2	50.0%	1	0	0.0	-2	0	2	26.6%
12/14	CHA	L 119-111	14	7	3	0	0	0	0	1	1	100.0%	2	2	100.0%	3	3	100.0%	0	0	0.0%	1	2	0.0	+0	2	8	116.7%
12/12	WAS	W 130-126	10	0	3	1	0	0	0	1	0	0.0%	1	0	0.0%	2	0	0.0%	0	0	0.0%	1	2	0.0	-3	6	5	0.0%
12/6	GSW	L 99-94	16	6	12	1	1	2	3	2	0	0.0%	8	3	37.5%	10	3	30.0%	0	0	0.0%	6	6	0.3	+1	0	11	30.0%
12/5	SAS	W 130-117	18	13	2	2	0	0	0	3	1	33.3%	7	4	57.1%	10	5	50.0%	4	2	50.0%	2	0	0.0	-7	2	10	55.3%
12/3	POR	L 122-110	15	7	4	1	0	2	0	3	1	33.3%	1	1	100.0%	4	2	50.0%	2	2	100.0%	1	3	0.0	+0	2	13	71.7%
12/1	IND	W 135-119	27	6	6	1	4	2	1	1	0	0.0%	5	2	40.0%	6	2	33.3%	2	2	100.0%	3	3	1.0	+15	2	12	43.6%
11/30	BOS	L 117-115	22	7	2	0	0	1	0	2	0	0.0%	3	3	100.0%	5	3	60.0%	2	1	50.0%	1	1	0.0	+19	4	5	59.5%
11/28	ATL	L 130-123	11	5	1	0	1	0	0	1	1	100.0%	2	1	50.0%	3	2	66.7%	0	0	0.0%	0	1	0.0	+9	2	4	83.3%
11/24	TOR	L 110-99	31	14	4	0	0	1	0	3	2	66.7%	5	4	80.0%	8	6	75.0%	0	0	0.0%	0	4	0.0	-5	4	12	87.5%
11/23	LAC	W 120-105	21	8	2	1	2	1	1	3	1	33.3%	2	2	100.0%	5	3	60.0%	2	1	50.0%	1	1	1.0	+12	3	8	68.0%
11/21	IND	W 120-109	11	2	0	0	0	0	0	1	0	0.0%	3	1	33.3%	4	1	25.0%	0	0	0.0%	0	0	0.0	-14	0	2	25.0%
11/19	HOU	L 114-104	19	10	2	0	0	0	0	5	0	0.0%	5	4	80.0%	10	4	40.0%	4	2	50.0%	2	0	0.0	-1	1	3	42.5%
11/17	MIL	W 118-106	12	2	2	1	1	0	1	1	0	0.0%	1	1	100.0%	2	1	50.0%	0	0	0.0%	1	1	1.0	+9	1	4	50.0%
11/15	MEM	W 108-100	17	2	4	1	2	1	0	1	0	0.0%	3	1	33.3%	4	1	25.0%	0	0	0.0%	1	3	0.0	+8	3	6	25.0%
11/13	TOR	L 126-113	21	18	6	0	0	2	0	1	0	0.0%	9	8	88.9%	10	8	80.0%	2	2	100.0%	5	1	0.0	-10	5	20	82.7%
11/12	MIA	W 130-116	17	9	6	2	1	2	1	4	0	0.0%	3	2	66.7%	7	2	28.6%	6	5	83.3%	4	2	2.0	+20	4	12	46.7%
11/7	WAS	W 148-115	5	6	2	0	1	1	0	1	0	0.0%	3	2	66.7%	4	2	50.0%	2	2	100.0%	1	1	0.0	+5	2	7	61.5%
11/5	PHI	W 132-121	1	0	0	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	+0	0	0	0.0%
Regular Season Totals			15.4	5.5	2.8	0.8	0.5	0.7	0.4	1.7	0.4	21.5%	3.0	1.9	61.8%	4.7	2.2	47.3%	0.9	0.7	75.4%	1.3	1.6	1.7	+57	2.0	7.8	53.9%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/23	TOR	L 126-104	2	0	1	1	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	1	0	0.0	+0	0	1	0.0%
4/18	TOR	W 126-113	2	2	0	0	0	0	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	0	0	0.0	-2	2	1	100.0%
Postseason Totals			2.3	1.0	0.5	0.5	0.0	0.0	0.5	0.0	0.0	0.0%	1.0	0.5	50.0%	1.0	0.5	50.0%	0.0	0.0	0.0%	0.5	0.0	1.0	-2	1.0	1.0	50.0%

Nae'Qwan Tomlin: Breaking News

Tomlin is not in Cleveland's starting lineup against Toronto on Saturday for Game 1 of the first round of the Eastern Conference playoffs. Tomlin made his third start of the 2025-26 campaign during this past Sunday's regular-season finale against the Wizards, when he played 36 minutes and finished with a career-high 26 points along with eight rebounds and five assists in a 130-117 win. Tomlin will return to a bench role for Game 1, though it's unclear how much playing time he'll see given that rotation tend to tighten up in the playoffs.

Tomlin had 26 points (9-16 FG, 4-8 3Pt, 4-4 FT), eight rebounds and five assists across 36 minutes during Sunday's 130-117 victory over the Wizards. Tomlin led the charge for the undermanned Cavaliers, scoring a career-high 26 points. While this was obviously an outlier, Tomlin should be given at least some credit, having managed to carve out a regular spot in the rotation this season. In 34 games over the past three months, he has averaged 5.4 points and 2.9 rebounds in 16.0 minutes per game.

Tomlin will start Sunday's game against the Wizards, Serena Winters of FanDuel Sports Network Ohio reports. Tomlin will make his third start of the season in the team's regular-season finale. The third-year pro has seen an increased role of late, averaging 6.5 points, 5.3 rebounds and 1.0 assists in 19.0 minutes per contest over his last four appearances.